NDC 16729-434 – Daptomycin

Daptomycin 350 mg/7mL · Injection, Powder, Lyophilized, For Solution · Intravenous

Human Prescription Drug 1 recall

Product NDC16729-434

Product details

Brand name
Daptomycin
Generic name
Daptomycin
Labeler
Accord Healthcare, Inc.
Dosage form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Marketing category
ANDA · ANDA212667
Marketed since
July 16, 2019
Listing expires
December 31, 2026
Pharmacologic class
Lipopeptide Antibacterial

Active ingredients

Uses, dosage, side effects and warnings for Daptomycin →

Package NDC codes (2)

Package NDCDescriptionSince
16729-434-051 VIAL in 1 CARTON (16729-434-05) / 7 mL in 1 VIALJul 16, 2019
16729-434-4510 VIAL in 1 CARTON (16729-434-45) / 7 mL in 1 VIALFeb 27, 2020

Recalls mentioning this NDC

Other Daptomycin products